Turn Biotechnologies

33 employees

Turn Biotechnologies is combating the effects of aging in the epigenome by repairing tissue at the cellular level with mRNA therapies.

Basic info

Industry

biotechnology research

Sectors

Research and Development

Biotechnology

Dermatology

osteoarthritis

Cellular Programming

mRNA

SCNT

R&D

Health Care

Cell Reprogramming

Therapeutics

Aging

Genetics

ophthalmology

Life Science

Date founded

2018

Funding rounds raised

Turn Biotechnologies raised undisclosed on April 11, 2022

Investors: Khosla Ventures, Shanda Group, ThreeD Capital Inc., Formic Ventures, Astellas Venture Capital L.L.C., LongeVC, HanAll BioPharma Co., Ltd and Methuselah Fund

Turn Biotechnologies raised undisclosed on April 28, 2021

Investors: Formic Ventures, Khosla Ventures and Shanda Group

Turn Biotechnologies raised undisclosed on August 26, 2019

Investors: Formic Ventures

Turn Biotechnologies raised undisclosed on June 6, 2019

Investors: KIZOO